Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0039730 (
thalassemia
)
10,305
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The seropositivity rate for the human immunodeficiency virus (HIV), the hepatitis B virus (HBV) and sexually transmitted diseases (
STO
) were evaluated in high-risk subjects related to a blood transfusion centre in Eastern India. Paid donors showed a high seropositivity rate for HBV and
STO
and a recent emergence of HIV seropositivity. The multitransfused subjects of
thalassaemia
and haemophilia showed HBV seropositivity rates of 18% and 38% respectively but haemophiliacs receiving blood components showed in addition a seropositivity of 3% for HIV. The laboratory staff and personnel of the blood bank and parents of patients with
thalassaemia
showed high carrier rates for HBV. A voluntary blood donation programme, rigid screening of blood for
STO
and HBV and training for proper handling of blood and blood products are essential requirements for a safe blood transfusion service. Screening for HIV seropositivity should be carried out in high-risk donors, patients requiring frequent transfusion and their contacts.
...
PMID:HIV, HBV and STD screening of high-risk subjects. 2985 56